A citation-based method for searching scientific literature

Laura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, Selcen Öztürk, Tobias Roider, Marie Bordas, Ana Izcue, Dolors Colomer, Sascha Dietrich, Stephan Stilgenbauer, Bola Hanna, José Ignacio Martín-Subero, Martina Seiffert. Leukemia 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein.
N Purroy, P Abrisqueta, J Carabia, C Carpio, E Calpe, C Palacio, J Castellví, M Crespo, F Bosch. Leukemia 2014
16
50


Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, K Döhner, M Bentz, P Lichter. N Engl J Med 2000
50


Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
Mojgan Ahmadzadeh, Laura A Johnson, Bianca Heemskerk, John R Wunderlich, Mark E Dudley, Donald E White, Steven A Rosenberg. Blood 2009
984
50

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.
Andrew M Intlekofer, Naofumi Takemoto, E John Wherry, Sarah A Longworth, John T Northrup, Vikram R Palanivel, Alan C Mullen, Christopher R Gasink, Susan M Kaech, Joseph D Miller,[...]. Nat Immunol 2005
833
50

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
D J DiLillo, J B Weinberg, A Yoshizaki, M Horikawa, J M Bryant, Y Iwata, T Matsushita, K M Matta, Y Chen, G M Venturi,[...]. Leukemia 2013
115
50

Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation.
J Adam Best, David A Blair, Jamie Knell, Edward Yang, Viveka Mayya, Andrew Doedens, Michael L Dustin, Ananda W Goldrath. Nat Immunol 2013
195
50

Overcoming T cell exhaustion in infection and cancer.
Kristen E Pauken, E John Wherry. Trends Immunol 2015
535
50

Growth dynamics in naturally progressing chronic lymphocytic leukaemia.
Michaela Gruber, Ivana Bozic, Ignaty Leshchiner, Dimitri Livitz, Kristen Stevenson, Laura Rassenti, Daniel Rosebrock, Amaro Taylor-Weiner, Oriol Olive, Reaha Goyetche,[...]. Nature 2019
37
50

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.
Andrea Schietinger, Mary Philip, Varintra E Krisnawan, Edison Y Chiu, Jeffrey J Delrow, Ryan S Basom, Peter Lauer, Dirk G Brockstedt, Sue E Knoblaugh, Günter J Hämmerling,[...]. Immunity 2016
268
50

Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia.
Verònica Fernàndez, Pedro Jares, Itziar Salaverria, Eva Giné, Sílvia Beà, Marta Aymerich, Dolors Colomer, Neus Villamor, Francesc Bosch, Emili Montserrat,[...]. Haematologica 2008
11
50

CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.
María Hernández-Sánchez, Jana Kotaskova, Ana E Rodríguez, Lenka Radova, David Tamborero, María Abáigar, Karla Plevova, Rocío Benito, Nikola Tom, Miguel Quijada-Álamo,[...]. Leukemia 2019
9
50

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
E N Smith, E M Ghia, C M DeBoever, L Z Rassenti, K Jepsen, K-A Yoon, H Matsui, S Rozenzhak, H Alakus, P J Shepard,[...]. Blood Cancer J 2015
24
50

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
Rebeqa Gunnarsson, Larry Mansouri, Anders Isaksson, Hanna Göransson, Nicola Cahill, Mattias Jansson, Markus Rasmussen, Jeanette Lundin, Stefan Norin, Anne Mette Buhl,[...]. Haematologica 2011
71
50

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Marta Crespo, Francesc Bosch, Neus Villamor, Beatriz Bellosillo, Dolors Colomer, María Rozman, Silvia Marcé, Armando López-Guillermo, Elies Campo, Emili Montserrat. N Engl J Med 2003
991
50

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.
John C Riches, Jeffrey K Davies, Fabienne McClanahan, Rewas Fatah, Sameena Iqbal, Samir Agrawal, Alan G Ramsay, John G Gribben. Blood 2013
298
50

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.
Shawn D Blackburn, Haina Shin, W Nicholas Haining, Tao Zou, Creg J Workman, Antonio Polley, Michael R Betts, Gordon J Freeman, Dario A A Vignali, E John Wherry. Nat Immunol 2009
50

IntOGen-mutations identifies cancer drivers across tumor types.
Abel Gonzalez-Perez, Christian Perez-Llamas, Jordi Deu-Pons, David Tamborero, Michael P Schroeder, Alba Jene-Sanz, Alberto Santos, Nuria Lopez-Bigas. Nat Methods 2013
327
50

Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study.
Alice Ramassone, Andrea D'Argenio, Angelo Veronese, Alessio Basti, Shimaa Hassan AbdelAziz Soliman, Stefano Volinia, Cristian Bassi, Sara Pagotto, Manuela Ferracin, Laura Lupini,[...]. J Hematol Oncol 2019
3
50

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.
David L Porter, Wei-Ting Hwang, Noelle V Frey, Simon F Lacey, Pamela A Shaw, Alison W Loren, Adam Bagg, Katherine T Marcucci, Angela Shen, Vanessa Gonzalez,[...]. Sci Transl Med 2015
953
50


Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
Sara S Alhakeem, Mary K McKenna, Karine Z Oben, Sunil K Noothi, Jacqueline R Rivas, Gerhard C Hildebrandt, Roger A Fleischman, Vivek M Rangnekar, Natarajan Muthusamy, Subbarao Bondada. J Immunol 2018
20
50

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.
Alan G Ramsay, Amy J Johnson, Abigail M Lee, Güllü Gorgün, Rifca Le Dieu, William Blum, John C Byrd, John G Gribben. J Clin Invest 2008
434
50

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Marzia Palma, Giusy Gentilcore, Kia Heimersson, Fariba Mozaffari, Barbro Näsman-Glaser, Emma Young, Richard Rosenquist, Lotta Hansson, Anders Österborg, Håkan Mellstedt. Haematologica 2017
68
50

The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Davide Brusa, Sara Serra, Marta Coscia, Davide Rossi, Giovanni D'Arena, Luca Laurenti, Ozren Jaksic, Giorgio Fedele, Giorgio Inghirami, Gianluca Gaidano,[...]. Haematologica 2013
132
50

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Ferran Nadeu, Julio Delgado, Cristina Royo, Tycho Baumann, Tatjana Stankovic, Magda Pinyol, Pedro Jares, Alba Navarro, David Martín-García, Sílvia Beà,[...]. Blood 2016
172
50

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.
Imane Azzaoui, Fabrice Uhel, Delphine Rossille, Celine Pangault, Joelle Dulong, Jerome Le Priol, Thierry Lamy, Roch Houot, Steven Le Gouill, Guillaume Cartron,[...]. Blood 2016
79
50

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.
Alena Gros, Paul F Robbins, Xin Yao, Yong F Li, Simon Turcotte, Eric Tran, John R Wunderlich, Arnold Mixon, Shawn Farid, Mark E Dudley,[...]. J Clin Invest 2014
594
50

CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.
Regina Jitschin, Martina Braun, Maike Büttner, Katja Dettmer-Wilde, Juliane Bricks, Jana Berger, Michael J Eckart, Stefan W Krause, Peter J Oefner, Katarina Le Blanc,[...]. Blood 2014
161
50

Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
Alexander C Leeksma, Justin Taylor, Bian Wu, Jeffrey R Gardner, Jie He, Michelle Nahas, Mithat Gonen, Wendimagegn G Alemayehu, Doreen Te Raa, Tatjana Walther,[...]. Leukemia 2019
31
50

Mutations driving CLL and their evolution in progression and relapse.
Dan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, Chip Stewart, Johannes G Reiter, Jasmin Bahlo, Sandra Kluth, Ivana Bozic, Mike Lawrence, Sebastian Böttcher,[...]. Nature 2015
565
50

T Cell Dysfunction in Cancer.
Daniela S Thommen, Ton N Schumacher. Cancer Cell 2018
348
50

Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection.
Charlly Kao, Kenneth J Oestreich, Michael A Paley, Alison Crawford, Jill M Angelosanto, Mohammed-Alkhatim A Ali, Andrew M Intlekofer, Jeremy M Boss, Steven L Reiner, Amy S Weinmann,[...]. Nat Immunol 2011
308
50

Estimation of copy number alterations from exome sequencing data.
Rafael Valdés-Mas, Silvia Bea, Diana A Puente, Carlos López-Otín, Xose S Puente. PLoS One 2012
15
50

Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer.
Jayendra Shinde, Quentin Bayard, Sandrine Imbeaud, Théo Z Hirsch, Feng Liu, Victor Renault, Jessica Zucman-Rossi, Eric Letouzé. Bioinformatics 2018
25
50

Chronic lymphocytic leukaemia: from genetics to treatment.
Francesc Bosch, Riccardo Dalla-Favera. Nat Rev Clin Oncol 2019
65
50

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
50

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.
M J J Rose-Zerilli, J Gibson, J Wang, W Tapper, Z Davis, H Parker, M Larrayoz, H McCarthy, R Walewska, J Forster,[...]. Leukemia 2016
28
50

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
Dan A Landau, Scott L Carter, Petar Stojanov, Aaron McKenna, Kristen Stevenson, Michael S Lawrence, Carrie Sougnez, Chip Stewart, Andrey Sivachenko, Lili Wang,[...]. Cell 2013
919
50

Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.
Bola S Hanna, Philipp M Roessner, Haniyeh Yazdanparast, Dolors Colomer, Elias Campo, Sabrina Kugler, Deyan Yosifov, Stephan Stilgenbauer, Manfred Schmidt, Richard Gabriel,[...]. Leukemia 2019
38
50


Multiparametric analysis of CD8+ T cell compartment phenotype in chronic lymphocytic leukemia reveals a signature associated with progression toward therapy.
Pauline Gonnord, Manon Costa, Arnaud Abreu, Michael Peres, Loïc Ysebaert, Sébastien Gadat, Salvatore Valitutti. Oncoimmunology 2019
4
50

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
T J Hamblin, Z Davis, A Gardiner, D G Oscier, F K Stevenson. Blood 1999
50

Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.
Wendelina J M Mackus, Florine N J Frakking, Annette Grummels, Laila E Gamadia, Godelieve J De Bree, Dorte Hamann, Rene A W Van Lier, Marinus H J Van Oers. Blood 2003
77
50


Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL.
Marwan Kwok, Ceri Oldreive, Andy C Rawstron, Anshita Goel, Grigorios Papatzikas, Rhiannon E Jones, Samantha Drennan, Angelo Agathanggelou, Archana Sharma-Oates, Paul Evans,[...]. Blood 2020
8
50

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner. Haematologica 2007
158
50

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.
Daniela S Thommen, Viktor H Koelzer, Petra Herzig, Andreas Roller, Marcel Trefny, Sarah Dimeloe, Anna Kiialainen, Jonathan Hanhart, Catherine Schill, Christoph Hess,[...]. Nat Med 2018
366
50

IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.
S Drennan, A D'Avola, Y Gao, C Weigel, E Chrysostomou, A J Steele, T Zenz, C Plass, P W Johnson, A P Williams,[...]. Leukemia 2017
17
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.